Sensitivity. All Data are considered confidential but not sensitive personal data.
Sensitivity. The sensitivity of the method is determined by the ability to measure the endogenous CO2 produc- tion of the inoculum in the blank flask and by the sensitivity limit of the dis- solved organic carbon analysis. If the test is adapted to handle 14C-labeled test substances, test substance con- centrations can be much lower.
Sensitivity. Master data are not considered personal sensitive. All other Data are considered personal sensitive.
Sensitivity. Personal data of the users are considered less sensitive. The content of approval Data, PDF-files and attachments are considered potentially personal sensitive, but beyond the control or influence of Continia.
Sensitivity. Better than *** pV per meter, at minimum
Sensitivity. Participation identifier refers to the company registered is considered less sensitive. The content of XML files can potentially be personal sensitive but beyond the control or influence of Continia. These data are not accessed in order to reach the intended endpoint. ANNEX III
Sensitivity. At the highest level of confidence (level 5, lesion definitely present), sensitivity for correctly localized malignant lesions on digital chest radiography varied from 18% (95% CI: 10%, 32%) to 49% (95% CI: 36%, 63%) at a specificity of 100% (95% CI: 94%, 100%) to 92% (95% CI: 82%, 97%). The false-positive rates in the control group at this level of con- fidence ranged from 0% (0 of 72) to 13% (9 of 72) for observers D and C, respectively. When lesions rated as probably present (level 4) were taken into ac- count, sensitivity increased to 36% (95% CI: 24%, 50%) for observer D and 73% (59%, 84%) for observer A, with specificities of 99% (95% CI: 50%, 76%) and 82% (95% CI: 71%, 90%), respectively (Table 3). Most lesions that had been rated as definitely present at chest radiography Figure 1
Sensitivity. >10e-7 cc/sec, 0.1 ppm (sniffer mode) >10e-11cc/sec (vacuum mode) 150 $700/wk 200 $700/wk $2000/month ❒ ❒ Additional week $500 ❒ ❒ $2000/month Additional week $500 TITANTEST ASM 182T ASM 142 (Sniffing Only) Need a rental while your leak detector gets repaired? Contact LACO for rental discounts — toll free at (000) 000-0000 NOTES: ASM 142S
Sensitivity. Serial dilutions were prepared from an A1AT ZZ phenotype sample with a total A1AT concentration of 24 mg/dL. The minimum detection limit of an A1AT isoform was about 6 mg/dL. Method Comparison Concordance studies were performed at 3 sites on 357 serum samples between the SPIFE Touch A1AT assay and a commercially available FDA cleared isoelectric focusing method. Thirty normal and 327 different pathological serum samples were run on both platforms. The total A1AT concentrations ranged between ≥20 mg/dL and ≤200 mg/dL. The data are summarized in the following table for Method Comparison. Site 1 N Agree Site 2 N Agree Site 3 N Agree Sites 1-3 N Agree MM 10 10 MM 10 10 MM 10 10 MM 30 30 MZ 20 20 MZ 20 20 MZ 18 18 MZ 58 58 MS 20 20 MS 20 20 MS 20 20 MS 60 60 ZZ 20 20 ZZ 20 20 ZZ 4 4 ZZ 44 44 SS 20 20 SS 20 20 SS NA NA SS 40 40 SZ 20 20 SZ 20 20 SZ 7 7 SZ 47 47 Null 16 16 Null NA NA Null NA NA Null 16 16 Other 46 46 Other 5 5 Other 11 11 Other 62 62 Totals 172 172 115 115 70 70 357 357 Overall % agreement = 357/357 = 100% There were no discordant results between the candidate and the comparator device. Clinical Performance We tested 172 clinically characterized samples. The clinical performance was assessed using the clinical diagnostic criteria cited in Xxxxxxx, et al., 2020.2 Based on these criteria the clinical sensitivity and specificity were the same as that of the predicate. BIBLIOGRAPHY
Sensitivity. The sensitivity of a surveillance system can be considered on two levels. First, at the level of case reporting, sensitivity refers to the proportion of cases of a disease (or other health-related event) detected by the surveillance system (Updated Guidelines for Evaluating Public Health Surveillance Systems: Recommendations from the Guidelines Working Group, MMWR, 2001). Second, sensitivity can refer to the ability to detect outbreaks, including the ability to monitor changes in the number of cases over time (Updated Guidelines for Evaluating Public Health Surveillance Systems: Recommendations from the Guidelines Working Group, MMWR, 2001). GHBS utilizes a data management system that can provide the proportion of cases of HIV/AIDS detected by the surveillance system. A comprehensive literature review of GHBS surveillance can provide information about the changes in the number of cases over time. The information extracted from the literature review will be the rates of HIV/AIDS amongst IDUs in the Atlanta Metropolitan area and any changes with HIV/AIDS rates that have occurred over time from IDU Cycle II to IDU Cycle III. Representativeness A public health surveillance system that is representative accurately describes the occurrence of a health-related event over time and its distribution in the population by place and person (Updated Guidelines for Evaluating Public Health Surveillance Systems: Recommendations from the Guidelines Working Group, MMWR, 2001). A comprehensive literature review of GHBS related documentation can provide information about the occurrence of HIV/AIDS from IDU Cycle II to IDU Cycle III. Timeliness Timeliness reflects the speed between steps in a public health surveillance system (Updated Guidelines for Evaluating Public Health Surveillance Systems: Recommendations from the Guidelines Working Group, MMWR, 2001). GHBS progress reports can determine the timeliness between steps taken to ensure proper implementation of the GHBS project. Progress reports can show what activities (steps) were taken and the amount of time it took to implement one activity prior to implementing the subsequent activity. Stability Stability refers to the reliability (i.e., the ability to collect, manage, and provide data properly without failure) and availability (the ability to be operational when it is needed) of the public health surveillance system (Updated Guidelines for Evaluating Public Health Surveillance Systems: Recommendations from the Guideline...
